Created at Source Raw Value Validated value
Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "experimental group:ebastine 10mg bid; nterferon-alpha aerosol inhalation 5million U bid and Lopinavir 200 mg; 2 capsules at a time; bid;control group:interferon-alpha aerosol inhalation 5million U bid and Lopinavir 200 mg; 2 capsules at a time; bid;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "experimental group:ebastine 10mg bid; nterferon-alpha aerosol inhalation 5million U bid and Lopinavir 200 mg; 2 capsules at a time; bid", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "control group:interferon-alpha aerosol inhalation 5million U bid and Lopinavir 200 mg; 2 capsules at a time; bid;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1590, "treatment_name": "Interferon alpha+lopinavir", "treatment_type": "Interferons+antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1602, "treatment_name": "Ebastine+interferon alpha+lopinavir", "treatment_type": "Respiratory agents+interferons+antivirals", "pharmacological_treatment": "Pharmacological treatment"}]